143 related articles for article (PubMed ID: 35187075)
21. Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.
Chen K; Luo CP; Ge DX; Wang KL; Luo Q; Li YZ; You XM; Xiang BD; Li LQ; Ma L; Zhong JH
Front Oncol; 2022; 12():946693. PubMed ID: 36276151
[TBL] [Abstract][Full Text] [Related]
22. [Long-term survival of a patient with multiple advanced hepatocellular carcinomas with portal vein tumor thrombus].
Sakamoto T; Kobayashi S; Tomimaru Y; Wada H; Akita H; Hama N; Kawamoto K; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1816-8. PubMed ID: 24393932
[TBL] [Abstract][Full Text] [Related]
23. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB
Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870
[TBL] [Abstract][Full Text] [Related]
24. [Multidisciplinary treatment for advanced hepatocellular carcinoma with portal vein tumor thrombosis and adrenal/lung metastases].
Mizumoto T; Beppu T; Okabe K; Sugiyama S; Nakagawa M; Okabe H; Doi K; Ishiko T; Yamanaka T; Egami H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1921-3. PubMed ID: 15553760
[TBL] [Abstract][Full Text] [Related]
25. Camrelizumab combined with lenvatinib in the treatment of gastric cancer with liver metastasis: a case report.
Wang K; Wang H; Lv Y; Liu H; Liu J; Zhang Y
Ann Palliat Med; 2021 Jan; 10(1):803-809. PubMed ID: 33545802
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for breast cancer progresses to liver metastases after surgery and systemic treatment.
Yin T; Nie L; Wu D; Liu B; Feng Y; Wu X; Luo C; Liang J
Transl Cancer Res; 2020 Feb; 9(2):993-1000. PubMed ID: 35117444
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hepatocellular carcinoma with portal vein thrombosis by sorafenib combined with hepatic arterial infusion chemotherapy.
Yang MY; Jeong SW; Kim DK; Kim SG; Jang JY; Kim YS; Lee JS; Kim BS; Kim JH; Kim YJ
Gut Liver; 2010 Sep; 4(3):423-7. PubMed ID: 20981227
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
Kodama K; Kawaoka T; Aikata H; Uchikawa S; Nishida Y; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Kimura T; Nagata Y; Chayama K
Oncology; 2018; 94(4):215-222. PubMed ID: 29428943
[TBL] [Abstract][Full Text] [Related]
29. [Successful treatment of metastatic hepatocellular carcinoma with sorafenib combined with transcatheter arterial chemoembolization/hepatic arterial infusion chemotherapy].
Watanabe Y; Nakaba H; Taniguchi E; Kikkawa H; Tamagawa H; Sasaki M; Kitayama T; Doi Y; Oguchi Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2110-2. PubMed ID: 25731439
[TBL] [Abstract][Full Text] [Related]
30. Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma.
Imai Y; Hirooka M; Koizumi Y; Nakamura Y; Watanabe T; Yoshida O; Tokumoto Y; Takeshita E; Abe M; Tanaka H; Kurata M; Kitazawa S; Hiasa Y
Radiol Case Rep; 2017 Mar; 12(1):179-184. PubMed ID: 28228906
[TBL] [Abstract][Full Text] [Related]
31. Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma.
Yoo EJ; Shin HS; Kim SU; Joo DJ; Park JY; Choi GH; Kim DY; Ahn SH; Seong J; Koh MJ; Han KH; Chon CY
Onco Targets Ther; 2013; 6():755-9. PubMed ID: 23836988
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of hepatocellular carcinoma with portal vein tumor thrombosis by CEUS before and after hepatic arterial infusion chemotherapy.
Kirikoshi H; Saito S; Ueno N; Suzuki K; Takahashi H; Yoneda M; Fujita K; Nakajima A
J Med Ultrason (2001); 2010 Jul; 37(3):137-41. PubMed ID: 27278013
[TBL] [Abstract][Full Text] [Related]
33. Response of Scalp and Skull Metastasis to Anti-PD-1 Antibody Combined with Regorafenib Treatment in a Sorafenib-Resistant Hepatocellular Carcinoma Patient and a Literature Review.
Long X; Zhang L; Wang WQ; Zhang EL; Lv X; Huang ZY
Onco Targets Ther; 2022; 15():703-716. PubMed ID: 35791424
[TBL] [Abstract][Full Text] [Related]
34. Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
Liu M; Shi J; Mou T; Wang Y; Wu Z; Shen A
J Gastroenterol Hepatol; 2020 Aug; 35(8):1277-1287. PubMed ID: 32052876
[TBL] [Abstract][Full Text] [Related]
35. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.
Khan AR; Wei X; Xu X
J Hepatocell Carcinoma; 2021; 8():1089-1115. PubMed ID: 34522691
[TBL] [Abstract][Full Text] [Related]
36. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K
J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102
[TBL] [Abstract][Full Text] [Related]
37. Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature.
Chu JH; Huang LY; Wang YR; Li J; Han SL; Xi H; Gao WX; Cui YY; Qian MP
World J Gastrointest Oncol; 2024 Apr; 16(4):1647-1659. PubMed ID: 38660668
[TBL] [Abstract][Full Text] [Related]
38. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
39. A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.
Kim HY; Kim JD; Bae SH; Park JY; Han KH; Woo HY; Choi JY; Yoon SK; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH;
Korean J Hepatol; 2010 Dec; 16(4):355-61. PubMed ID: 21415578
[TBL] [Abstract][Full Text] [Related]
40. Pathological complete remission of advanced hepatocellular carcinoma with main portal vein tumor thrombosis by hepatic arterial infusion chemotherapy.
Kim YG; Eun JR; Kim TN; Lee HJ; Kim JW; Chang JC; Yun SS; Choi JH
Gut Liver; 2010 Jun; 4(2):266-9. PubMed ID: 20559534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
